Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220791353> ?p ?o ?g. }
- W4220791353 abstract "Prostate cancer is a major health issue in western countries and is the second leading cause of cancer death in American men. Prostate cancer depends on the androgen receptor (AR), a transcriptional factor critical for prostate cancer growth and progression. Castration by surgery or medical treatment reduces androgen levels, resulting in prostatic atrophy and prostate cancer regression. Thus, metastatic prostate cancers are initially managed with androgen deprivation therapy. Unfortunately, prostate cancers rapidly relapse after castration therapy and progress to a disease stage called castration-resistant prostate cancer (CRPC). Currently, clinical treatment for CRPCs is focused on suppressing AR activity with antagonists like Enzalutamide or by reducing androgen production with Abiraterone. In clinical practice, these treatments fail to yield a curative benefit in CRPC patients in part due to AR gene mutations or splicing variations, resulting in AR reactivation. It is conceivable that eliminating the AR protein in prostate cancer cells is a promising solution to provide a potential curative outcome. Multiple strategies have emerged, and several potent agents that reduce AR protein levels were reported to eliminate xenograft tumor growth in preclinical models via distinct mechanisms, including proteasome-mediated degradation, heat-shock protein inhibition, AR splicing suppression, blockage of AR nuclear localization, AR N-terminal suppression. A few small chemical compounds are undergoing clinical trials combined with existing AR antagonists. AR protein elimination by enhanced protein or mRNA degradation is a realistic solution for avoiding AR reactivation during androgen deprivation therapy in prostate cancers." @default.
- W4220791353 created "2022-04-03" @default.
- W4220791353 creator A5020637697 @default.
- W4220791353 creator A5039126001 @default.
- W4220791353 creator A5084681260 @default.
- W4220791353 date "2022-03-10" @default.
- W4220791353 modified "2023-10-14" @default.
- W4220791353 title "Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective" @default.
- W4220791353 cites W1508200717 @default.
- W4220791353 cites W1611419331 @default.
- W4220791353 cites W1882606371 @default.
- W4220791353 cites W1907272683 @default.
- W4220791353 cites W1982732414 @default.
- W4220791353 cites W1985360090 @default.
- W4220791353 cites W1989656600 @default.
- W4220791353 cites W2007069676 @default.
- W4220791353 cites W2013367051 @default.
- W4220791353 cites W2015306991 @default.
- W4220791353 cites W2017839954 @default.
- W4220791353 cites W2017919614 @default.
- W4220791353 cites W2018556051 @default.
- W4220791353 cites W2025031463 @default.
- W4220791353 cites W2034233153 @default.
- W4220791353 cites W2035179289 @default.
- W4220791353 cites W2036976345 @default.
- W4220791353 cites W2039921125 @default.
- W4220791353 cites W2049866636 @default.
- W4220791353 cites W2053273553 @default.
- W4220791353 cites W2053535211 @default.
- W4220791353 cites W2059097089 @default.
- W4220791353 cites W2073615418 @default.
- W4220791353 cites W2081365151 @default.
- W4220791353 cites W2084308735 @default.
- W4220791353 cites W2084891840 @default.
- W4220791353 cites W2086878176 @default.
- W4220791353 cites W2093549201 @default.
- W4220791353 cites W2097226696 @default.
- W4220791353 cites W2106571316 @default.
- W4220791353 cites W2113606874 @default.
- W4220791353 cites W2116506777 @default.
- W4220791353 cites W2117857186 @default.
- W4220791353 cites W2117991391 @default.
- W4220791353 cites W2118238803 @default.
- W4220791353 cites W2121846636 @default.
- W4220791353 cites W2129509993 @default.
- W4220791353 cites W2136344158 @default.
- W4220791353 cites W2144941480 @default.
- W4220791353 cites W2150775704 @default.
- W4220791353 cites W2151683271 @default.
- W4220791353 cites W2158567574 @default.
- W4220791353 cites W2160463964 @default.
- W4220791353 cites W2282380036 @default.
- W4220791353 cites W2293714014 @default.
- W4220791353 cites W2316757416 @default.
- W4220791353 cites W2325609367 @default.
- W4220791353 cites W2345499901 @default.
- W4220791353 cites W2403561089 @default.
- W4220791353 cites W2404879427 @default.
- W4220791353 cites W2464082044 @default.
- W4220791353 cites W2562980568 @default.
- W4220791353 cites W2605070587 @default.
- W4220791353 cites W2611741716 @default.
- W4220791353 cites W2612456082 @default.
- W4220791353 cites W2612804612 @default.
- W4220791353 cites W2616577186 @default.
- W4220791353 cites W2622721717 @default.
- W4220791353 cites W2728922891 @default.
- W4220791353 cites W2737233173 @default.
- W4220791353 cites W2745650147 @default.
- W4220791353 cites W2750934051 @default.
- W4220791353 cites W2760948449 @default.
- W4220791353 cites W2773909295 @default.
- W4220791353 cites W2790041008 @default.
- W4220791353 cites W2802540286 @default.
- W4220791353 cites W2805314109 @default.
- W4220791353 cites W2806590927 @default.
- W4220791353 cites W2841328798 @default.
- W4220791353 cites W2883077013 @default.
- W4220791353 cites W2886821920 @default.
- W4220791353 cites W2888707204 @default.
- W4220791353 cites W2892275487 @default.
- W4220791353 cites W2893677139 @default.
- W4220791353 cites W2901189223 @default.
- W4220791353 cites W2907942589 @default.
- W4220791353 cites W2908533946 @default.
- W4220791353 cites W2908623381 @default.
- W4220791353 cites W2909034820 @default.
- W4220791353 cites W2911554916 @default.
- W4220791353 cites W2914799280 @default.
- W4220791353 cites W2918028648 @default.
- W4220791353 cites W2921684231 @default.
- W4220791353 cites W2922703066 @default.
- W4220791353 cites W2924804970 @default.
- W4220791353 cites W2929595741 @default.
- W4220791353 cites W2932844691 @default.
- W4220791353 cites W2939558853 @default.
- W4220791353 cites W2942551831 @default.
- W4220791353 cites W2949704476 @default.
- W4220791353 cites W2952560670 @default.
- W4220791353 cites W2953400134 @default.